<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>13</Volume>
      <Issue>5</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>10</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Immunopathology of Sarcoidosis</title>
    <FirstPage>300</FirstPage>
    <LastPage>306</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Esmaeil</FirstName>
        <LastName>Mortaz</LastName>
        <affiliation locale="en_US">Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands AND Chronic Respiratory Diseases Research Center and National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Department of Immunology, ShahidBeheshti &#xA0;University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Masjedi</LastName>
        <affiliation locale="en_US">Respiratory Diseases Research Center and National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Department of Immunology, ShahidBeheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Payam</FirstName>
        <LastName>Tabarsi</LastName>
        <affiliation locale="en_US">Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mihan</FirstName>
        <LastName>Pourabdollah</LastName>
        <affiliation locale="en_US">Chronic Respiratory Diseases Research Center and National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Department of Immunology, ShahidBeheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ian M</FirstName>
        <LastName>Adcock</LastName>
        <affiliation locale="en_US">Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The immunopathology of sarcoidosis remains elusive despite years of research into this multiorgan disease.However, recent studies have provided new insights into the genetics and immune components involved in the clinical manifestation of the disease.
Granulomatous inflammation is due to the host immune response to a persistent poorly degradable unknown antigen.Mycobacterium tuberculosis (MTB) is the major disease driver in many patients.
The&#xA0; immune&#xA0; mechanisms&#xA0; that&#xA0; cause this&#xA0; disease start&#xA0; with&#xA0; the&#xA0; antigenic stimulus, followed by T-cell, macrophage and dendritic cell activation via a classic MHC II&#x2013;mediated pathway.
In addition, the profile of immune mediators reported in sarcoidosis indicates that the inflammasome pathway plays a critical role in disease pathogenesis. Increased understanding of the signal &#xA0;ransductions pathways involved in the induction of inflammatory processes in sarcoidosis could give rise to new therapeutic approaches in future.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/440</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/440/397</pdf_url>
  </Article>
</Articles>
